Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A radiology report on a wooden table with an imaging machine in the background.

Jun 10, 2026

Rad AI Expands Partnership With Yale New Haven Health For Radiology AI Deployment

Rad AI is enhancing its collaboration with Yale New Haven Health to implement its advanced radiology AI technology across the health system's extensive imaging network.The California-based company aims to improve radiology workflows by automating key aspects of the reporting process, notably reducing the time required for physician dictation and follow-up care management. This partnership will see the deployment of Rad AI’s solutions across over 16 outpatient imaging centers and five hospital ca
A minimalist illustration of a DNA strand and data points representing precision oncology.

Jun 10, 2026

Sophia Genetics, Memorial Sloan Kettering Sign Strategic Collaboration for AI-Powered Precision Oncology Hub

Memorial Sloan Kettering Cancer Center and Sophia Genetics have announced a strategic collaboration to create an AI-powered precision oncology hub aimed at enhancing cancer care through advanced analytics and clinical expertise.The partnership will leverage Memorial Sloan Kettering's extensive clinical datasets and expertise along with Sophia Genetics' AI-driven analytics platform. This initiative seeks to establish a global hub for precision medicine, integrating the strengths of both organizat
Healthcare worker using a hospital management system in a dimly lit room

Jun 10, 2026

Raigad Chosen as ABDM ‘Model District’ as Maharashtra Pushes Ahead with Digital Health Transformation

Raigad has been designated as a 'Model District' under the Ayushman Bharat Digital Mission (ABDM), marking a significant step in Maharashtra's digital health transformation efforts.The designation aims to enhance digital healthcare services, improve health record integration, and foster a connected healthcare ecosystem. All 383 government health facilities in Raigad have successfully adopted ABDM-enabled Hospital Management Information Systems (HMIS), with ongoing efforts to include private heal
A minimalist representation of an eye with retinal blood vessels

Jun 10, 2026

Gates Foundation Backs Remidio’s AI Retinal Scans to Detect Pregnancy Risks in Africa & India

The Gates Foundation is supporting Remidio's innovative AI technology, which utilizes retinal scans to identify pregnancy-related risks in underserved areas of Africa and India.Remidio, a digital health startup based in Bangalore, has secured funding from the Gates Foundation to enhance maternal healthcare through its AI-enabled retinal scanning technology. This initiative aims to identify complications associated with pregnancy, such as pre-eclampsia and gestational diabetes, by leveraging the
A flat illustration of a tumor cell with abstract AI shapes.

Jun 10, 2026

Tempus AI (TEM) Valuation Check As FDA Approval And New AI Tools Shape Growth Expectations

Tempus AI (TEM) is making headlines with recent FDA approval for its xT CDx tumor-only sequencing platform and enhancements to its AI tools for cancer testing. However, despite these advancements, the stock has underperformed, closing at $48.82, down over 21% year-to-date.With annual revenues of approximately $1.36 billion and a market cap around $8.73 billion, the company faces ongoing losses of $302.91 million. Analysts suggest that the current share price may not reflect its potential, with a
Flat illustration of an isolated gate driver for high-voltage applications

Jun 10, 2026

NOVOSENSE Highlights Latest IC Advancements Across Automotive, White Goods, Industrial Control, and AI Data Center Power at PCIM Europe 2026

NOVOSENSE Microelectronics is showcasing innovative integrated circuit (IC) technologies at PCIM Europe 2026, focusing on applications in automotive, white goods, industrial control, and AI data centers.The company is highlighting advancements in IC solutions for various sectors, emphasizing functional safety and isolation in high-voltage electric vehicle (EV) power conversion. Notable products include an ASIL D isolated gate driver designed for SiC and IGBT power stages, which features a high c
Research notes in a collaborative workspace

Jun 10, 2026

Sofinnova Partners Launches Collaboration with AWS to Scale AI Across Life Sciences Innovation

Sofinnova Partners has partnered with Amazon Web Services (AWS) to enhance the integration of AI within the life sciences sector, aiming to accelerate the development of innovative therapies.This collaboration focuses on Sofinnova.AI, which aims to embed AI across various investment processes and support for portfolio companies. A key aspect is the expansion of Sofia, Sofinnova's proprietary AI platform, which will now include a version designed specifically for founders. This move is intended t
A minimalist illustration of a computer mouse and stethoscope representing telehealth.

Jun 10, 2026

American Well Corp stock (US03044L1052): Telehealth player navigates market headwinds after latest e

American Well Corp, known as Amwell, is recalibrating its telehealth strategy amid a challenging market landscape, as reflected in its latest quarterly results. Investors are closely monitoring how these changes will impact the company's stock performance in the evolving digital health sector.Despite being a prominent player in the telehealth space, Amwell faces significant pressures from budget constraints within health systems and broader economic uncertainties. The company is pivoting towards
A minimalist representation of a lipid nanoparticle in a dark color scheme.

Jun 10, 2026

AllerGene AI Therapeutics Appoints Biotech Industry Veteran Gad Berdugo to Board of Directors

AllerGene AI Therapeutics has appointed Gad Berdugo to its Board of Directors, enhancing its strategic growth efforts following a significant investment from Explorium Capital.On June 9, 2026, AllerGene AI Therapeutics, a company focused on pioneering in vivo targeted-lipid nanoparticle (tLNP) mRNA chimeric antigen receptor (CAR) therapies for severe allergic and mast cell-driven diseases, announced the appointment of Gad Berdugo as an independent board member. This move coincides with an invest
A diagnostic device on a lab countertop with a patient sample in the background.

Jun 10, 2026

Noul joins government's Global Hidden Champion 1000+ Project

Noul, a company specializing in AI-driven diagnostics, has been recognized as a "Growth Enterprise" in the South Korean government's Global Hidden Champion 1000+ Project, aimed at boosting export-oriented SMEs.This initiative, led by the Ministry of SMEs and Startups, focuses on identifying small and medium-sized enterprises with significant growth potential and offers various support mechanisms such as export vouchers, financing options, and research and development assistance. Noul's selection
Flat design of a small-molecule drug and GPCR icon

Jun 10, 2026

XTALPI (02228.HK) Enters Strategic AI Drug Discovery Collaboration with International Pharma Worth Over USD400 Million

XTALPI has formed a significant strategic partnership with an international biopharmaceutical firm to co-develop an innovative oral small-molecule drug aimed at targeting G protein-coupled receptors (GPCRs).This collaboration follows a successful pilot phase where XTALPI utilized its advanced platform, integrating quantum physics and AI algorithms, to enhance its drug discovery hit rate. Under the terms of the agreement, the biopharmaceutical partner will provide an upfront payment and cover all
A blood sample in a test tube on a lab bench

Jun 9, 2026

Machine Learning Model Enhances Precision of Liquid Biopsy Diagnostics

Researchers at Johns Hopkins Kimmel Cancer Center have developed a groundbreaking machine learning model named plasmaCHORD, aimed at enhancing the accuracy of mutation identification in liquid biopsies for cancer diagnostics. This innovative tool significantly improves the clinical decision-making process by effectively distinguishing between cancer-derived mutations and those from other biological processes, which is crucial for targeted therapeutic interventions.Liquid biopsies have revolution